Dr. Martens Statistics

Total Valuation

Dr. Martens has a market cap or net worth of GBP 791.01 million. The enterprise value is 1.04 billion.

Market Cap	791.01M
Enterprise Value	1.04B

Important Dates

The last earnings date was Thursday, June 5, 2025.

Earnings Date	Jun 5, 2025
Ex-Dividend Date	Aug 28, 2025

Share Statistics

Dr. Martens has 965.23 million shares outstanding. The number of shares has decreased by -1.17% in one year.

Current Share Class	965.23M
Shares Outstanding	965.23M
Shares Change (YoY)	-1.17%
Shares Change (QoQ)	+6.06%
Owned by Insiders (%)	0.90%
Owned by Institutions (%)	48.92%
Float	500.07M

Valuation Ratios

The trailing PE ratio is 175.26 and the forward PE ratio is 18.82.

PE Ratio	175.26
Forward PE	18.82
PS Ratio	1.00
PB Ratio	2.16
P/TBV Ratio	8.56
P/FCF Ratio	4.21
P/OCF Ratio	4.03
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.18, with an EV/FCF ratio of 5.53.

EV / Earnings	230.93
EV / Sales	1.32
EV / EBITDA	8.18
EV / EBIT	17.12
EV / FCF	5.53

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 1.10.

Current Ratio	2.59
Quick Ratio	1.37
Debt / Equity	1.10
Debt / EBITDA	3.18
Debt / FCF	2.15
Interest Coverage	2.01

Financial Efficiency

Return on equity (ROE) is 1.23% and return on invested capital (ROIC) is 4.70%.

Return on Equity (ROE)	1.23%
Return on Assets (ROA)	4.12%
Return on Invested Capital (ROIC)	4.70%
Return on Capital Employed (ROCE)	8.30%
Revenue Per Employee	299,468
Profits Per Employee	1,711
Employee Count	2,630
Asset Turnover	0.86
Inventory Turnover	1.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.38% in the last 52 weeks. The beta is 0.15, so Dr. Martens's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-2.38%
50-Day Moving Average	55.44
200-Day Moving Average	61.98
Relative Strength Index (RSI)	83.35
Average Volume (20 Days)	1,766,852

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Martens had revenue of GBP 787.60 million and earned 4.50 million in profits. Earnings per share was 0.00.

Revenue	787.60M
Gross Profit	511.70M
Operating Income	60.70M
Pretax Income	8.80M
Net Income	4.50M
EBITDA	75.70M
EBIT	60.70M
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 155.90 million in cash and 404.10 million in debt, giving a net cash position of -248.20 million or -0.26 per share.

Cash & Cash Equivalents	155.90M
Total Debt	404.10M
Net Cash	-248.20M
Net Cash Per Share	-0.26
Equity (Book Value)	366.40M
Book Value Per Share	0.38
Working Capital	252.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 196.30 million and capital expenditures -8.40 million, giving a free cash flow of 187.90 million.

Operating Cash Flow	196.30M
Capital Expenditures	-8.40M
Free Cash Flow	187.90M
FCF Per Share	0.19

Full Cash Flow Statement

Margins

Gross margin is 64.97%, with operating and profit margins of 7.71% and 0.57%.

Gross Margin	64.97%
Operating Margin	7.71%
Pretax Margin	1.12%
Profit Margin	0.57%
EBITDA Margin	9.61%
EBIT Margin	7.71%
FCF Margin	23.86%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.38%.

Dividend Per Share	0.03
Dividend Yield	3.38%
Dividend Growth (YoY)	-68.49%
Years of Dividend Growth	n/a
Payout Ratio	211.11%
Buyback Yield	1.17%
Shareholder Yield	4.55%
Earnings Yield	0.57%
FCF Yield	23.75%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Martens has an Altman Z-Score of 4.97.

Altman Z-Score	4.97
Piotroski F-Score	n/a